Biotech · Private company

DermBiont, Inc.

Track this companyFree. Adds DermBiont, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials60 recruiting or active

Pipeline programs12From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline12

A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Melanoma Skin CancersPHASE2 · UNKNOWN · started Mar 25, 2024ClinicalTrials.gov NCT06409195 · fetched Nov 12, 2026
A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Dermatosis Papulosa Nigra (DPN)PHASE2 · UNKNOWN · started Nov 7, 2023ClinicalTrials.gov NCT06099080 · fetched Nov 12, 2026
A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic KeratosisPHASE2 · UNKNOWN · started Nov 6, 2023ClinicalTrials.gov NCT06108024 · fetched Nov 12, 2026
A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With OnychomycosisPHASE2 · SUSPENDED · started Nov 1, 2023ClinicalTrials.gov NCT05491603 · fetched Nov 12, 2026
A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea PedisPHASE2 · UNKNOWN · started Sep 8, 2022ClinicalTrials.gov NCT05493488 · fetched Nov 12, 2026
Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous GelPHASE2 · TERMINATED · started Oct 6, 2021ClinicalTrials.gov NCT05253755 · fetched Nov 12, 2026